JP2020188753A - Beverage flavor-improver - Google Patents
Beverage flavor-improver Download PDFInfo
- Publication number
- JP2020188753A JP2020188753A JP2020051468A JP2020051468A JP2020188753A JP 2020188753 A JP2020188753 A JP 2020188753A JP 2020051468 A JP2020051468 A JP 2020051468A JP 2020051468 A JP2020051468 A JP 2020051468A JP 2020188753 A JP2020188753 A JP 2020188753A
- Authority
- JP
- Japan
- Prior art keywords
- beverage
- blank
- flavor
- isoleucine
- improving agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013361 beverage Nutrition 0.000 title claims abstract description 106
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims abstract description 76
- 238000000855 fermentation Methods 0.000 claims abstract description 41
- 230000004151 fermentation Effects 0.000 claims abstract description 41
- 241000894006 Bacteria Species 0.000 claims abstract description 38
- 235000014655 lactic acid Nutrition 0.000 claims abstract description 38
- 239000004310 lactic acid Substances 0.000 claims abstract description 38
- WHUUTDBJXJRKMK-GSVOUGTGSA-N D-glutamic acid Chemical compound OC(=O)[C@H](N)CCC(O)=O WHUUTDBJXJRKMK-GSVOUGTGSA-N 0.000 claims abstract description 35
- CKLJMWTZIZZHCS-UWTATZPHSA-N D-aspartic acid Chemical compound OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 claims abstract description 30
- 229930182847 D-glutamic acid Natural products 0.000 claims abstract description 30
- 235000019640 taste Nutrition 0.000 claims abstract description 27
- 235000019658 bitter taste Nutrition 0.000 claims abstract description 22
- 239000000796 flavoring agent Substances 0.000 claims description 45
- 235000019634 flavors Nutrition 0.000 claims description 45
- 239000003795 chemical substances by application Substances 0.000 claims description 29
- 229960000310 isoleucine Drugs 0.000 claims description 24
- 241000186660 Lactobacillus Species 0.000 claims description 16
- 229940039696 lactobacillus Drugs 0.000 claims description 16
- 241000186605 Lactobacillus paracasei Species 0.000 claims description 6
- 238000004519 manufacturing process Methods 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- 241000186679 Lactobacillus buchneri Species 0.000 claims description 4
- 241000186604 Lactobacillus reuteri Species 0.000 claims description 4
- 229940001882 lactobacillus reuteri Drugs 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 2
- AGPKZVBTJJNPAG-CRCLSJGQSA-N D-allo-isoleucine Chemical compound CC[C@H](C)[C@@H](N)C(O)=O AGPKZVBTJJNPAG-CRCLSJGQSA-N 0.000 abstract description 13
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 abstract description 8
- 230000035622 drinking Effects 0.000 abstract description 4
- 238000011156 evaluation Methods 0.000 description 107
- 230000000052 comparative effect Effects 0.000 description 71
- 239000000047 product Substances 0.000 description 37
- 239000000203 mixture Substances 0.000 description 35
- 230000001953 sensory effect Effects 0.000 description 34
- 238000009472 formulation Methods 0.000 description 25
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 24
- 239000000284 extract Substances 0.000 description 20
- 241000209094 Oryza Species 0.000 description 18
- 235000007164 Oryza sativa Nutrition 0.000 description 18
- 235000009566 rice Nutrition 0.000 description 18
- 239000007858 starting material Substances 0.000 description 17
- 238000002360 preparation method Methods 0.000 description 14
- 229940038487 grape extract Drugs 0.000 description 13
- 239000000243 solution Substances 0.000 description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 11
- 230000001476 alcoholic effect Effects 0.000 description 11
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 10
- 239000002994 raw material Substances 0.000 description 10
- 229930182844 L-isoleucine Natural products 0.000 description 9
- 238000001212 derivatisation Methods 0.000 description 9
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 8
- 229940041514 candida albicans extract Drugs 0.000 description 8
- 239000008103 glucose Substances 0.000 description 8
- 239000007788 liquid Substances 0.000 description 8
- 239000000843 powder Substances 0.000 description 8
- 239000012138 yeast extract Substances 0.000 description 8
- 238000004458 analytical method Methods 0.000 description 7
- 235000013405 beer Nutrition 0.000 description 7
- PXEDJBXQKAGXNJ-QTNFYWBSSA-L disodium L-glutamate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](N)CCC([O-])=O PXEDJBXQKAGXNJ-QTNFYWBSSA-L 0.000 description 7
- XMXOIHIZTOVVFB-JIZZDEOASA-L disodium;(2s)-2-aminobutanedioate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](N)CC([O-])=O XMXOIHIZTOVVFB-JIZZDEOASA-L 0.000 description 7
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 238000010438 heat treatment Methods 0.000 description 6
- CONKBQPVFMXDOV-QHCPKHFHSA-N 6-[(5S)-5-[[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]methyl]-2-oxo-1,3-oxazolidin-3-yl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C[C@H]1CN(C(O1)=O)C1=CC2=C(NC(O2)=O)C=C1 CONKBQPVFMXDOV-QHCPKHFHSA-N 0.000 description 5
- 150000008574 D-amino acids Chemical class 0.000 description 5
- 229960002989 glutamic acid Drugs 0.000 description 5
- FYELSNVLZVIGTI-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-5-ethylpyrazol-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C=1C=NN(C=1CC)CC(=O)N1CC2=C(CC1)NN=N2 FYELSNVLZVIGTI-UHFFFAOYSA-N 0.000 description 4
- 229940024606 amino acid Drugs 0.000 description 4
- 235000001014 amino acid Nutrition 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- 235000020094 liqueur Nutrition 0.000 description 4
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 3
- 240000001929 Lactobacillus brevis Species 0.000 description 3
- 235000013957 Lactobacillus brevis Nutrition 0.000 description 3
- 241000186840 Lactobacillus fermentum Species 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 235000013922 glutamic acid Nutrition 0.000 description 3
- 239000004220 glutamic acid Substances 0.000 description 3
- 229940012969 lactobacillus fermentum Drugs 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 241000207199 Citrus Species 0.000 description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-Glutamic acid Natural products OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
- PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 description 2
- 240000006024 Lactobacillus plantarum Species 0.000 description 2
- 235000013965 Lactobacillus plantarum Nutrition 0.000 description 2
- 241000535433 Lactobacillus reuteri JCM 1112 Species 0.000 description 2
- MKYBYDHXWVHEJW-UHFFFAOYSA-N N-[1-oxo-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propan-2-yl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(C(C)NC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 MKYBYDHXWVHEJW-UHFFFAOYSA-N 0.000 description 2
- NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 2
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 235000020971 citrus fruits Nutrition 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 235000019674 grape juice Nutrition 0.000 description 2
- 229940072205 lactobacillus plantarum Drugs 0.000 description 2
- ZWLUXSQADUDCSB-UHFFFAOYSA-N phthalaldehyde Chemical compound O=CC1=CC=CC=C1C=O ZWLUXSQADUDCSB-UHFFFAOYSA-N 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- CKLJMWTZIZZHCS-UHFFFAOYSA-N Aspartic acid Chemical compound OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 240000000560 Citrus x paradisi Species 0.000 description 1
- 239000004129 EU approved improving agent Substances 0.000 description 1
- 235000008694 Humulus lupulus Nutrition 0.000 description 1
- 240000001046 Lactobacillus acidophilus Species 0.000 description 1
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 description 1
- 244000199866 Lactobacillus casei Species 0.000 description 1
- 235000013958 Lactobacillus casei Nutrition 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241000219095 Vitis Species 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229960005261 aspartic acid Drugs 0.000 description 1
- 229910021538 borax Inorganic materials 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- UQGFMSUEHSUPRD-UHFFFAOYSA-N disodium;3,7-dioxido-2,4,6,8,9-pentaoxa-1,3,5,7-tetraborabicyclo[3.3.1]nonane Chemical compound [Na+].[Na+].O1B([O-])OB2OB([O-])OB1O2 UQGFMSUEHSUPRD-UHFFFAOYSA-N 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229940039695 lactobacillus acidophilus Drugs 0.000 description 1
- 229940017800 lactobacillus casei Drugs 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 150000003212 purines Chemical class 0.000 description 1
- 235000010339 sodium tetraborate Nutrition 0.000 description 1
- 239000004328 sodium tetraborate Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 235000019583 umami taste Nutrition 0.000 description 1
- 238000011514 vinification Methods 0.000 description 1
Images
Landscapes
- Alcoholic Beverages (AREA)
- Non-Alcoholic Beverages (AREA)
- Distillation Of Fermentation Liquor, Processing Of Alcohols, Vinegar And Beer (AREA)
Abstract
Description
本発明は、飲料の風味を改善する飲料用風味改善剤に関する。 The present invention relates to a beverage flavor improving agent for improving the flavor of a beverage.
近年、健康志向の高まりと共に、アルコール濃度が1%未満のビール風味飲料、並びにアルコール濃度が1〜10v/v%のビール風味低アルコール飲料であって低糖質のものやプリン体の含有量が低いものに対する需要が高まっている。また、同じくビール風味以外でも、柑橘風味を初めとした様々な風味のリキュール類含有低アルコール飲料であって、低糖質のものやプリン体の含有量が低いものに対する需要が高まっている。このような飲料において、より満足感の得られる飲みごたえ、より自然な風味を呈する飲料を実現するため、日々企業努力がなされている。 In recent years, with increasing health consciousness, beer-flavored beverages with an alcohol concentration of less than 1%, and beer-flavored low-alcohol beverages with an alcohol concentration of 1 to 10 v / v%, which have a low sugar content and a low content of purines. The demand for things is increasing. In addition to beer flavors, there is an increasing demand for low-alcohol beverages containing liqueurs and other flavors such as citrus flavors, which have low sugar content and low purine content. In such beverages, corporate efforts are being made every day to realize beverages that are more satisfying to drink and have a more natural flavor.
しかし、アルコール濃度が1%未満のビール風味飲料、並びにアルコール濃度が1〜10v/v%のビール風味低アルコール飲料、及びリキュール類含有低アルコール飲料であって低糖質のものやプリン体の含有量が低いものは、飲みごたえ、特にボディ感に物足りなさを感じる傾向があるという問題点があった。 However, beer-flavored beverages with an alcohol concentration of less than 1%, beer-flavored low-alcohol beverages with an alcohol concentration of 1 to 10 v / v%, and low-alcohol beverages containing liqueurs with low sugar content and purine content. Those with a low content had the problem that they tended to feel unsatisfactory, especially in the body feeling.
加えて、低糖質やプリン体の含有量を低くするためには原料配合を減らす必要があるため、ビール風味飲料やビール風味低アルコール飲料にて原料ホップに由来する苦味が弱まってしまい、一方で苦味料等を使用すると苦味が不自然となってしまうという課題がある。ビール風味低アルコール飲料では、更にアルコール由来の苦味が加わるため、同じように苦味が不自然となる課題がある。 In addition, since it is necessary to reduce the amount of raw materials in order to reduce the content of low sugar and purine, the bitterness derived from the raw material hops is weakened in beer-flavored beverages and beer-flavored low-alcohol beverages. There is a problem that the bitterness becomes unnatural when a bitterness agent or the like is used. The beer-flavored low-alcohol beverage has a problem that the bitterness becomes unnatural because the bitterness derived from alcohol is further added.
これらの課題は、同じく苦味を有する原料を含む柑橘風味などのリキュール類含有低アルコール飲料でも当てはまり、ボディ感と自然な苦みの両立が求められている。 These issues also apply to low-alcohol beverages containing liqueurs such as citrus flavors containing raw materials that also have a bitter taste, and it is required to achieve both a body feeling and natural bitterness.
そこで、前記課題を解決する手段は、以下のとおりである。
〔1〕 D−アスパラギン酸、D−グルタミン酸、及びD−アロ−イソロイシンを含有する飲料用風味改善剤。
〔2〕 さらに、乳酸菌により発酵処理された発酵処理物を含有する〔1〕に記載の飲料用風味改善剤。
〔3〕 前記D−アスパラギン酸、D−グルタミン酸、及びD−アロ−イソロイシンが、乳酸菌による発酵処理によって生成されたものであることを特徴とする〔1〕または〔2〕に記載の飲料用風味改善剤。
〔4〕 前記乳酸菌がラクトバチルス属から選ばれる乳酸菌である〔2〕または〔3〕に記載の飲料用風味改善剤。
〔5〕 前記乳酸菌がラクトバチルス・ロイテリ、ラクトバチルス・パラカゼイ、ラクトバチルス・ブフネリ、ラクトバチルス・サンフランシセンシスから選ばれる乳酸菌である〔4〕に記載の飲料用風味改善剤。
〔6〕 改善される風味がボディ感であることを特徴とする〔1〕〜〔5〕のいずれかに記載の飲料用風味改善剤。
〔7〕 改善される風味が、ボディ感及び苦みの向上による味のバランスであることを特徴とする〔1〕〜〔5〕のいずれかに記載の飲料用風味改善剤。
〔8〕 〔1〕〜〔7〕のいずれかに記載の飲料用風味改善剤が含まれてなるビール風味飲料。
〔9〕 〔1〕〜〔7〕のいずれかに記載の飲料用風味改善剤が含まれてなる柑橘風味飲料。
〔10〕 〔1〕〜〔7〕のいずれかに記載の飲料用風味改善剤が含まれてなる低アルコール飲料。
〔11〕 発酵対象物を乳酸菌により発酵処理させて発酵物を生成すると共に、前記発酵処理によってD−アスパラギン酸、D−グルタミン酸、及びD−アロ−イソロイシンを生成し、前記D−アスパラギン酸、D−グルタミン酸、及びD−アロ−イソロイシンをその生成と同時に前記発酵物と混合させることを特徴とする飲料用風味改善剤の製造方法。
〔12〕 飲料中にD−アスパラギン酸を0.009ppm以上、D−グルタミン酸を0.029ppm以上、及びD−アロ−イソロイシンを0.004ppm以上含有させることを特徴とする、飲料の風味改善方法。
Therefore, the means for solving the above problems are as follows.
[1] A beverage flavor improving agent containing D-aspartic acid, D-glutamic acid, and D-aro-isoleucine.
[2] The beverage flavor improving agent according to [1], which further contains a fermented product fermented with lactic acid bacteria.
[3] The beverage flavor according to [1] or [2], wherein the D-aspartic acid, D-glutamic acid, and D-allo-isoleucine are produced by fermentation treatment with lactic acid bacteria. Improving agent.
[4] The beverage flavor improving agent according to [2] or [3], wherein the lactic acid bacterium is a lactic acid bacterium selected from the genus Lactobacillus.
[5] The beverage flavor improving agent according to [4], wherein the lactic acid bacterium is a lactic acid bacterium selected from Lactobacillus reuteri, Lactobacillus paracasei, Lactobacillus buchneri, and Lactobacillus sanfrancisensis.
[6] The beverage flavor improving agent according to any one of [1] to [5], wherein the flavor to be improved is a body feeling.
[7] The beverage flavor improving agent according to any one of [1] to [5], wherein the improved flavor is a balance of taste due to an improvement in body feeling and bitterness.
[8] A beer-flavored beverage containing the beverage flavor improving agent according to any one of [1] to [7].
[9] A citrus-flavored beverage comprising the beverage flavor-improving agent according to any one of [1] to [7].
[10] A low-alcohol beverage comprising the beverage flavor improving agent according to any one of [1] to [7].
[11] The fermentation target is fermented with lactic acid bacteria to produce a fermented product, and the fermentation treatment produces D-aspartic acid, D-glutamic acid, and D-allo-isoleucine, and the D-aspartic acid and D are produced. A method for producing a flavor improving agent for beverages, which comprises mixing glutamic acid and D-aro-isoleucine with the fermented product at the same time as the production thereof.
[12] A method for improving the flavor of a beverage, which comprises containing 0.009 ppm or more of D-aspartic acid, 0.029 ppm or more of D-glutamic acid, and 0.004 ppm or more of D-aro-isoleucine in the beverage.
ここで、ビール風味飲料とは、アルコール濃度が1v/v%未満のビール風の呈味を有する飲料をいう。また、低アルコール飲料とは、アルコール濃度が1v/v%以上〜10v/v%未満のビール風味低アルコール飲料、若しくはリキュール類含有低アルコール飲料をいう。 Here, the beer-flavored beverage refers to a beverage having a beer-like taste having an alcohol concentration of less than 1 v / v%. The low-alcohol beverage refers to a beer-flavored low-alcohol beverage having an alcohol concentration of 1 v / v% or more and less than 10 v / v%, or a low-alcohol beverage containing liqueurs.
本発明に係る発酵処理に使用される乳酸菌としては、ラクトバチルス・ブレビス(Lb.brevis)、ラクトバチルス・アシドフィルス(Lb.acidophilus)、ラクトバチルス・カゼイ(Lb.casei)、ラクトバチルス・パラカゼイ(Lb.paracasei)、ラクトバチルス・ロイテリ(Lb.reuteri)、ラクトバチルス・ファーメンタム(Lb.fermentum)、ラクトバチルス・デルブルッキー・サブスピーシーズ・ブルガリカス(Lb.delbruekii ssp. bulgaricus)、ラクトバチルス・プランタラム(Lb.plantarum)、ラクトバチルス・ブフネリ(Lb.buchneri)、ラクトバチルス・サンフランシセンシス(Lb.sanfranciscensis)、ラクトバチルス・マリ(Lb.mali)、などが挙げられ、これらから選ばれる一種または二種以上を使用することができる。 Examples of the lactic acid bacteria used in the fermentation treatment according to the present invention include Lactobacillus brevis (Lb. Brevis), Lactobacillus acidophilus (Lb. Acidophilus), Lactobacillus casei (Lb. Casei), and Lactobacillus paracasei (Lb). .Paracassei), Lactobacillus reuteri (Lb.reuteri), Lactobacillus fermentum (Lb.fermentum), Lactobacillus delbrucky subspecies bulgaricus (Lb.delluekii ssp.bulgaricus), lactobacillus (Lb.plantarum), Lactobacillus buchneri, Lactobacillus sanfrancisensis, Lactobacillus mari (Lb.mali), and the like, and one or two species selected from these. The above can be used.
上記の菌種の菌株としては、ラクトバチルス・ブレビスとしては、ラクトバチルス・ブレビス JCM1059等の菌株が挙げられ、ラクトバチルス・パラカゼイとしては、ラクトバチルス・パラカゼイJCM20315等の菌株が挙げられる。また、ラクトバチルス・ロイテリとしては、ラクトバチルス・ロイテリJCM1112等の菌株が挙げられる。また、ラクトバチルス・ファーメンタムとしては、ラクトバチルス・ファーメンタムJCM1137等の菌株が挙げられる。また、ラクトバチルス・デルブルッキー・サブスピーシーズ・ブルガリカスとしてはラクトバチルス・デルブルッキー・サブスピーシーズ・ブルガリカスJCM1002等の菌株が挙げられる。また、ラクトバチルス・プランタラムとしては、ラクトバチルス・プランタラムJCM1149等の菌株が挙げられ、ラクトバチルス・ブフネリとしては、ラクトバチルス・ブフネリJCM1115等の菌株が挙げられる。また、ラクトバチルス・サンフランシセンシスとしては、ラクトバチルス・サンフランシセンシスJCM5668等の菌株が挙げられ、ラクトバチルス・マリとしてはラクトバチルス・マリJCM1116等の菌株が挙げられる。以上の菌株は、独立行政法人製品評価技術基盤機構生物遺伝資源部門、独立行政法人理化学研究所バイオリソースセンターなど国内外の公的微生物保存機関から分譲を受けることが可能である。 Examples of the strains of the above strains include strains such as Lactobacillus brevis JCM1059 as Lactobacillus brevis, and strains such as Lactobacillus paracasei JCM20315 as lactobacillus paracasei. Examples of Lactobacillus reuteri include strains such as Lactobacillus reuteri JCM1112. In addition, examples of Lactobacillus fermentum include strains such as Lactobacillus fermentum JCM1137. In addition, examples of Lactobacillus del Brooky Subspecies Bulgaricus include strains such as Lactobacillus del Brooky Subspecies Bulgaricus JCM1002. Examples of lactobacillus plantarum include strains such as lactobacillus plantarum JCM1149, and examples of lactobacillus bufuneri include strains such as lactobacillus bufuneri JCM1115. Examples of Lactobacillus sanfrancicensis include strains such as Lactobacillus sanfrancicensis JCM5668, and examples of Lactobacillus mari are strains such as Lactobacillus mari JCM1116. The above strains can be sold by public microbial preservation organizations in Japan and overseas, such as the National Institute of Technology and Bioresources, Incorporated Administrative Agency, RIKEN BioResource Center.
本発明に係る飲料用風味改善剤をビール風味飲料、及び低アルコール飲料に添加することで、飲料のボディ感を高めることができた。さらに、飲料のボディ感、苦味、味のキレ、味のバランスの全てで呈味の向上効果が得られ、飲料としての総合的な官能評価の向上と共に飲みごたえと自然な苦みを付加させることができる。 By adding the beverage flavor improving agent according to the present invention to a beer-flavored beverage and a low-alcohol beverage, the body feeling of the beverage could be enhanced. Furthermore, the effect of improving the taste can be obtained in all of the body feeling, bitterness, sharpness of taste, and balance of taste of the beverage, and it is possible to improve the overall sensory evaluation as a beverage and add a feeling of drinking and natural bitterness. it can.
特に、本発明に係る飲料用風味改善剤を添加して飲料を調製すると、明確にボディ感と苦味、味のバランスを向上させることができる。これにより、ビール風味飲料、及び低アルコール飲料に対して十分な飲みごたえと自然な苦みを両立させることができる。 In particular, when a beverage is prepared by adding the beverage flavor improving agent according to the present invention, the balance between body feeling, bitterness and taste can be clearly improved. As a result, it is possible to achieve both sufficient mouthfeel and natural bitterness for beer-flavored beverages and low-alcohol beverages.
<乳酸菌スターターの調製例>
水96重量部、酵母エキス(粉体)2重量部、グルコース2重量部からなる培養基を調製し、該培養基を121℃で15分間殺菌し、その後37℃まで冷却した。次いで冷却後の培養基にラクトバチルス・ロイテリ(Lb.reuteri)JCM1112株0.02重量部を接種し、37℃で20時間培養させた発酵物をJCM1112スターターとした。
<Preparation example of lactic acid bacteria starter>
A culture group consisting of 96 parts by weight of water, 2 parts by weight of yeast extract (powder), and 2 parts by weight of glucose was prepared, and the culture group was sterilized at 121 ° C. for 15 minutes and then cooled to 37 ° C. Next, 0.02 parts by weight of Lactobacillus reuteri JCM1112 strain was inoculated into the cooled culture medium, and the fermented product cultured at 37 ° C. for 20 hours was used as a JCM1112 starter.
水96重量部、酵母エキス(粉体)2重量部、グルコース2重量部からなる培養基を調製し、該培養基を121℃で15分間殺菌し、その後37℃まで冷却した。次いで冷却後の培養基にラクトバチルス・パラカゼイ(Lb.paracasei)JCM20315株0.02重量部を接種し、37℃で20時間培養させた発酵物をJCM20315スターターとした。 A culture group consisting of 96 parts by weight of water, 2 parts by weight of yeast extract (powder), and 2 parts by weight of glucose was prepared, and the culture group was sterilized at 121 ° C. for 15 minutes and then cooled to 37 ° C. Next, 0.02 parts by weight of Lactobacillus paracasei JCM20315 strain was inoculated into the cooled culture medium, and the fermented product cultured at 37 ° C. for 20 hours was used as a JCM20315 starter.
水96重量部、酵母エキス(粉体)2重量部、グルコース2重量部からなる培養基を調製し、該培養基を121℃で15分間殺菌し、その後30℃まで冷却した。次いで冷却後の培養基にラクトバチルス・ブフネリ(Lb.buchneri)JCM1115株0.02重量部を接種し、30℃で20時間培養させた発酵物をJCM1115スターターとした。 A culture group consisting of 96 parts by weight of water, 2 parts by weight of yeast extract (powder), and 2 parts by weight of glucose was prepared, and the culture group was sterilized at 121 ° C. for 15 minutes and then cooled to 30 ° C. Next, 0.02 parts by weight of Lactobacillus buchneri JCM1115 strain was inoculated into the culture medium after cooling, and the fermented product cultured at 30 ° C. for 20 hours was used as a JCM1115 starter.
水96重量部、酵母エキス(粉体)2重量部、グルコース2重量部からなる培養基を調製し、該培養基を121℃で15分間殺菌し、その後30℃まで冷却した。次いで冷却後の培養基にラクトバチルス・サンフランシセンシス(Lb.sanfranciscensis)JCM5668株0.02重量部を接種し、30℃で20時間培養させた発酵物をJCM5668スターターとした。 A culture group consisting of 96 parts by weight of water, 2 parts by weight of yeast extract (powder), and 2 parts by weight of glucose was prepared, and the culture group was sterilized at 121 ° C. for 15 minutes and then cooled to 30 ° C. Next, 0.02 part by weight of Lb. sanfrancissensis JCM5668 strain was inoculated into the culture medium after cooling, and the fermented product cultured at 30 ° C. for 20 hours was used as a JCM5668 starter.
<実施例1−1:乳酸菌発酵液の調製例>
グルコース2重量部、酵母エキス(粉体)2重量部、水94.79重量部、L−アスパラギン酸ナトリウム0.2重量部、L−グルタミン酸ナトリウム0.2重量部、L−イソロイシン0.05重量部を混合し、湯煎にて90℃で1分間殺菌し、その後37℃まで冷却した。冷却した原料混合物に対し、上記で調製したJCM1112スターターを1重量部接種し、37℃で24時間発酵させた。発酵の停止は80℃で1分間加熱することで行い、得られた発酵物を実施例1−1とした。
<Example 1-1: Preparation example of lactic acid bacterium fermented liquid>
2 parts by weight of glucose, 2 parts by weight of yeast extract (powder), 94.79 parts by weight of water, 0.2 parts by weight of sodium L-aspartate, 0.2 parts by weight of sodium L-glutamate, 0.05 parts by weight of L-isoleucine The parts were mixed, sterilized in hot water at 90 ° C. for 1 minute, and then cooled to 37 ° C. 1 part by weight of the JCM1112 starter prepared above was inoculated into the cooled raw material mixture and fermented at 37 ° C. for 24 hours. Fermentation was stopped by heating at 80 ° C. for 1 minute, and the obtained fermented product was designated as Example 1-1.
<実施例1−2:乳酸菌発酵液の調製例>
グルコース2重量部、酵母エキス(粉体)2重量部、水94.79重量部、L−アスパラギン酸ナトリウム0.2重量部、L−グルタミン酸ナトリウム0.2重量部、L−イソロイシン0.05重量部を混合し、湯煎にて90℃で1分間殺菌し、その後37℃まで冷却した。冷却した原料混合物に対し、上記で調製したJCM20315スターターを1重量部接種し、37℃で24時間発酵させた。発酵の停止は80℃で1分間加熱することで行い、得られた発酵物を実施例1−2とした。
<Example 1-2: Preparation example of lactic acid bacterium fermented liquid>
2 parts by weight of glucose, 2 parts by weight of yeast extract (powder), 94.79 parts by weight of water, 0.2 parts by weight of sodium L-aspartate, 0.2 parts by weight of sodium L-glutamate, 0.05 parts by weight of L-isoleucine The parts were mixed, sterilized in hot water at 90 ° C. for 1 minute, and then cooled to 37 ° C. 1 part by weight of the JCM20315 starter prepared above was inoculated into the cooled raw material mixture and fermented at 37 ° C. for 24 hours. Fermentation was stopped by heating at 80 ° C. for 1 minute, and the obtained fermented product was designated as Example 1-2.
<実施例1−3:乳酸菌発酵液の調製例>
グルコース2重量部、酵母エキス(粉体)2重量部、水94.79重量部、L−アスパラギン酸ナトリウム0.2重量部、L−グルタミン酸ナトリウム0.2重量部、L−イソロイシン0.05重量部を混合し、湯煎にて90℃で1分間殺菌し、その後37℃まで冷却した。冷却した原料混合物に対し、上記で調製したJCM1115スターターを1重量部接種し、30℃で24時間発酵させた。発酵の停止は80℃で1分間加熱することで行い、得られた発酵物を実施例1−3とした。
<Example 1-3: Preparation example of lactic acid bacterium fermented liquid>
2 parts by weight of glucose, 2 parts by weight of yeast extract (powder), 94.79 parts by weight of water, 0.2 parts by weight of sodium L-aspartate, 0.2 parts by weight of sodium L-glutamate, 0.05 parts by weight of L-isoleucine The parts were mixed, sterilized in hot water at 90 ° C. for 1 minute, and then cooled to 37 ° C. 1 part by weight of the JCM1115 starter prepared above was inoculated into the cooled raw material mixture and fermented at 30 ° C. for 24 hours. Fermentation was stopped by heating at 80 ° C. for 1 minute, and the obtained fermented product was designated as Example 1-3.
<実施例1−4:乳酸菌発酵液の調製例>
グルコース2重量部、酵母エキス(粉体)2重量部、水94.79重量部、L−アスパラギン酸ナトリウム0.2重量部、L−グルタミン酸ナトリウム0.2重量部、L−イソロイシン0.05重量部を混合し、湯煎にて90℃で1分間殺菌し、その後37℃まで冷却した。冷却した原料混合物に対し、上記で調製したJCM5668スターターを1重量部接種し、30℃で24時間発酵させた。発酵の停止は80℃で1分間加熱することで行い、得られた発酵物を実施例1−4とした。
<Example 1-4: Preparation example of lactic acid bacterium fermented liquid>
2 parts by weight of glucose, 2 parts by weight of yeast extract (powder), 94.79 parts by weight of water, 0.2 parts by weight of sodium L-aspartate, 0.2 parts by weight of sodium L-glutamate, 0.05 parts by weight of L-isoleucine The parts were mixed, sterilized in hot water at 90 ° C. for 1 minute, and then cooled to 37 ° C. 1 part by weight of the JCM5668 starter prepared above was inoculated into the cooled raw material mixture and fermented at 30 ° C. for 24 hours. Fermentation was stopped by heating at 80 ° C. for 1 minute, and the obtained fermented product was designated as Example 1-4.
<実施例1−5:D−アミノ酸添加乳酸菌未発酵液の調製例>
前記実施例1−1のうちJCM1112スターターを水で置き換え、乳酸菌発酵工程以外で同様の操作を行い、さらに、実施例1−1と等濃度となるようにD−アスパラギン酸、D−グルタミン酸、D−アロ−イソロイシンを添加し、D−アミノ酸添加未発酵液を実施例1−5として調製した。
<Example 1-5: Preparation example of unfermented lactic acid bacterium supplemented with D-amino acid>
In Example 1-1, the JCM1112 starter was replaced with water, and the same operation was performed except for the lactic acid bacteria fermentation step. Further, D-aspartic acid, D-glutamic acid, and D were obtained so as to have the same concentration as that of Example 1-1. -Alo-isoleucine was added, and a D-amino acid-added unfermented solution was prepared as Example 1-5.
<比較例1:乳酸菌未発酵液の調製例>
前記実施例1−1のうち、JCM1112スターターを水で置き換え、乳酸菌発酵工程以外で同様の操作を行い、未発酵液を比較例1として調製した。
<Comparative Example 1: Preparation Example of Unfermented Lactic Acid Bacteria>
In Example 1-1, the JCM1112 starter was replaced with water, and the same operation was performed except for the lactic acid bacterium fermentation step, and an unfermented liquid was prepared as Comparative Example 1.
<実施例2:発酵米エキスの調製例>
上新粉15重量部と水83.8重量部、L−アスパラギン酸ナトリウム0.1重量部、L−グルタミン酸ナトリウム0.1重量部、L−イソロイシン0.05重量部を混合し、更にアミラーゼ0.01重量部を加え、でんぷん質を分解した後、湯煎にて90℃で1分間殺菌し、その後37℃まで冷却した(ここまでの工程で調製したものを、発酵対象物としての米エキスということがある。)。冷却した原料混合物に対し、上記で調製したJCM1112スターターを1重量部接種し、37℃で24時間発酵させた。発酵後、加熱により乳酸菌を殺菌し、遠心分離により固形物を除去したものを実施例2とした。
<Example 2: Preparation example of fermented rice extract>
15 parts by weight of Joshinko, 83.8 parts by weight of water, 0.1 parts by weight of sodium L-aspartate, 0.1 parts by weight of sodium L-glutamate, 0.05 parts by weight of L-isoleucine are mixed, and amylase is 0. After adding 0.01 part by weight to decompose the starch, it was sterilized in hot water at 90 ° C. for 1 minute and then cooled to 37 ° C. (the product prepared by the steps up to this point is called rice extract as a fermentation target. Sometimes.). 1 part by weight of the JCM1112 starter prepared above was inoculated into the cooled raw material mixture and fermented at 37 ° C. for 24 hours. Example 2 was obtained in which lactic acid bacteria were sterilized by heating after fermentation and solids were removed by centrifugation.
<比較例2:未発酵米エキスの調製例>
「実施例2:発酵米エキスの調製例」のうちJCM1112スターターを水で置き換え、乳酸菌発酵工程以外で同様の操作を行い、未発酵米エキスを比較例2として調製した。
<Comparative Example 2: Preparation Example of Unfermented Rice Extract>
In "Example 2: Preparation example of fermented rice extract", the JCM1112 starter was replaced with water, and the same operation was performed except for the lactic acid bacteria fermentation step, and the unfermented rice extract was prepared as Comparative Example 2.
<実施例3:発酵モルトエキスの調製例>
モルトエキス25重量部と水71.8重量部、L−アスパラギン酸ナトリウム0.1重量部、L−グルタミン酸ナトリウム0.1重量部、L−イソロイシン0.05重量部を混合し、湯煎にて90℃で1分間殺菌し、その後37℃まで冷却した(ここまでの工程で調製したものを、発酵対象物としてのモルトエキスということがある。)。冷却した原料混合物に対し、上記で調製したJCM1112スターターを3重量部接種し、37℃で24時間発酵させた。発酵の停止は80℃で1分間加熱することで行った。10℃以下まで冷却後、遠心分離にて清澄化し発酵モルトエキスを調製し、得られた発酵物を実施例3とした。
<Example 3: Preparation example of fermented malt extract>
Mix 25 parts by weight of malt extract, 71.8 parts by weight of water, 0.1 part by weight of sodium L-aspartate, 0.1 part by weight of sodium L-glutamate, and 0.05 part by weight of L-isoleucine, and boil 90 parts by weight. It was sterilized at ° C. for 1 minute and then cooled to 37 ° C. (the one prepared in the steps up to this point may be referred to as a malt extract as a fermentation target). The cooled raw material mixture was inoculated with 3 parts by weight of the JCM1112 starter prepared above and fermented at 37 ° C. for 24 hours. Fermentation was stopped by heating at 80 ° C. for 1 minute. After cooling to 10 ° C. or lower, the mixture was clarified by centrifugation to prepare a fermented malt extract, and the obtained fermented product was designated as Example 3.
<比較例3:未発酵モルトエキスの調製例>
前記「実施例3:発酵モルトエキスの調製方法」のうちJCM1112スターターを水で置き換え、乳酸菌発酵工程以外で同様の操作を行い、未発酵モルトエキスを比較例3として調製した。
<Comparative Example 3: Preparation Example of Unfermented Malt Extract>
In the above "Example 3: Method for preparing fermented malt extract", the JCM1112 starter was replaced with water, and the same operation was performed except for the lactic acid bacterium fermentation step, and the unfermented malt extract was prepared as Comparative Example 3.
<実施例4:発酵白ブドウエキスの調製例>
シャルドネ透明果汁25重量部と水71.8重量部、L−アスパラギン酸ナトリウム0.1重量部、L−グルタミン酸ナトリウム0.1重量部、L−イソロイシン0.05重量部を混合し、湯煎にて90℃で1分間殺菌し、その後37℃まで冷却した(ここまでの工程で調製したものを、発酵対象物としての白ブドウエキスということがある。)。冷却した原料混合物に対し、上記で調製したJCM1112スターターを3重量部接種し、37℃で24時間発酵させ、得られた発酵物を実施例4とした。
<Example 4: Preparation example of fermented white grape extract>
25 parts by weight of Chardonnay clear juice, 71.8 parts by weight of water, 0.1 parts by weight of sodium L-aspartate, 0.1 parts by weight of sodium L-glutamate, 0.05 parts by weight of L-isoleucine are mixed and boiled in hot water. It was sterilized at 90 ° C. for 1 minute and then cooled to 37 ° C. (the product prepared by the steps up to this point may be referred to as white grape extract as a fermentation target). 3 parts by weight of the JCM1112 starter prepared above was inoculated into the cooled raw material mixture and fermented at 37 ° C. for 24 hours, and the obtained fermented product was designated as Example 4.
<比較例4:未発酵白ブドウエキスの調製例>
前記「実施例4:発酵白ブドウエキスの製造例」のうち、JCM1112スターターを水に置き換え、乳酸菌発酵工程以外で同様の操作を行い、未発酵白ブドウエキスを比較例4として調製した。
<Comparative Example 4: Preparation Example of Unfermented White Grape Extract>
In the above "Example 4: Production example of fermented white grape extract", the JCM1112 starter was replaced with water, and the same operation was performed except for the lactic acid bacteria fermentation step, and the unfermented white grape extract was prepared as Comparative Example 4.
<D−アミノ酸量の測定>
実施例1−1〜1−5(乳酸菌発酵液)、実施例2(発酵米エキス)、実施例3(発酵モルトエキス)、および実施例4(発酵白ブドウエキス)、並びに比較例1〜4中のD−アスパラギン酸(D−Asp)、L−アスパラギン酸(L−Asp)、D−グルタミン酸(D−Glu)、L−グルタミン酸(L−Glu)、D−アロ−イソロイシン(D−aIle)、及びL−イソロイシン(L−Ile)の含有量は、次に示すオルトフタルアルデヒド・N−アセチル−L−システインキラル誘導体化法(OPA−NACキラル誘導体化法)を用いたアミノ酸定量分析により測定した。
<Measurement of D-amino acid amount>
Examples 1-1-1-5 (lactic acid bacterium fermented liquid), Example 2 (fermented rice extract), Example 3 (fermented malt extract), and Example 4 (fermented white grape extract), and Comparative Examples 1 to 4. D-aspartic acid (D-Asp), L-aspartic acid (L-Asp), D-glutamic acid (D-Glu), L-glutamic acid (L-Glu), D-aro-isoleucine (D-aIle) , And the content of L-isoleucine (L-Ile) are measured by quantitative amino acid analysis using the following orthophthalaldehyde / N-acetyl-L-cysteine chiral derivatization method (OPA-NAC chiral derivatization method). did.
まず、それぞれの実施例に係る液体状の発酵物に対し、2倍量のメタノールを加え撹拌後、遠心分離機にかけて得られる上清を蒸留水で3倍に希釈したものをキラル誘導体化用試料とした。なお、発酵物に含まれるアミノ酸量に応じ、上清を直接もしくは、蒸留水にて2倍から5倍に希釈したものをキラル誘導体化用試料とすることができる。 First, a sample for chiral derivatization is obtained by adding twice the amount of methanol to the liquid fermented product according to each example, stirring the mixture, and then centrifuging the supernatant and diluting the supernatant with distilled water three times. And said. Depending on the amount of amino acids contained in the fermented product, the supernatant can be directly diluted or diluted 2 to 5 times with distilled water as a sample for chiral derivatization.
<キラル誘導体化手順>
キラル誘導体化用試料60μlに1%四ホウ酸ナトリウム水溶液40μl、1%N−アセチル−L−システイン水溶液20μl、1.6%オルト−フタルアルデヒドメタノール溶液20μlを添加し、0.45μmセルロースアセテート製メンブレンフィルター(アドバンテック社製)でろ過したものをキラル誘導体化処理液とした。キラル誘導体化処理液を分析用試料として、高速液体クロマトグラフィー(HPLC、(株)島津製作所製、検出限界値:0.5ppm)によるアミノ酸分析を行った。
<Chiral derivatization procedure>
To 60 μl of a chiral derivatization sample, 40 μl of a 1% aqueous sodium tetraborate solution, 20 μl of a 1% N-acetyl-L-cysteine aqueous solution, and 20 μl of a 1.6% ortho-phthalaldehyde methanol solution were added, and a 0.45 μm cellulose acetate membrane was added. The solution filtered with a filter (manufactured by Advantech) was used as a chiral derivatization treatment solution. Amino acid analysis was performed by high performance liquid chromatography (HPLC, manufactured by Shimadzu Corporation, detection limit value: 0.5 ppm) using the chiral derivatization treatment solution as a sample for analysis.
また、キラル誘導体化処理液を分析用試料としたHPLCによるアミノ酸分析にあたり、分析条件としては、次の表1に示す条件を選択した。また、分析の結果を表2に示す。 Further, in the amino acid analysis by HPLC using the chiral derivatization treatment solution as the sample for analysis, the conditions shown in Table 1 below were selected as the analysis conditions. The results of the analysis are shown in Table 2.
表2より、未発酵の比較例1、及び比較例2〜4からはD−アスパラギン酸、D−グルタミン酸、D−アロ−イソロイシンの含有量はHPLCの検出限界値である0.5ppmよりも低い値であったのに対して、乳酸菌により発酵処理された発酵物である実施例1−1〜1−5、及び実施例2〜4からは高い濃度のD−アスパラギン酸、D−グルタミン酸、D−アロ−イソロイシンが検出された。また、実施例1−5では、未発酵の状態のまま実施例1−1とほぼ同濃度のD−アスパラギン酸、D−グルタミン酸、D−アロ−イソロイシンが含まれていることが確認された。表2の結果より、発酵処理前にはほとんど存在していなかったD−アスパラギン酸、D−グルタミン酸、D−アロ−イソロイシンを発酵処理によって高濃度に生成すると共に、その生成と同時に発酵物に混合された状態の飲料用風味改善剤を製造することができた。 From Table 2, the contents of D-aspartic acid, D-glutamic acid, and D-aro-isoleucine from the unfermented Comparative Examples 1 and 2 to 4 are lower than the HPLC detection limit of 0.5 ppm. In contrast to the values, high concentrations of D-aspartic acid, D-glutamic acid, and D from Examples 1-1 to 1-5 and Examples 2 to 4, which are fermented products fermented by lactic acid bacteria, were obtained. -Alo-isoleucine was detected. Further, in Example 1-5, it was confirmed that D-aspartic acid, D-glutamic acid, and D-aro-isoleucine were contained in the unfermented state in substantially the same concentration as in Example 1-1. From the results in Table 2, D-aspartic acid, D-glutamic acid, and D-allo-isoleucine, which were hardly present before the fermentation treatment, were produced in high concentrations by the fermentation treatment and mixed with the fermented product at the same time as the production. It was possible to produce a flavor-improving agent for beverages in the state of being fermented.
<飲料用風味改善剤を添加した飲料の呈味官能試験> <Taste sensory test of beverages to which flavor improver for beverages has been added>
前記実施例1−1〜1−5、及び実施例2〜4に係る飲料用風味改善剤を添加したビール風味飲料、及び低アルコール飲料の呈味について、前記比較例1、及び比較例2〜4を添加したビール風味飲料、及び低アルコール飲料の呈味と比較しつつ、官能試験を行った。 Regarding the tastes of the beer-flavored beverages to which the beverage flavor improving agents according to Examples 1-1 to 1-5 and Examples 2 to 4 were added, and the low-alcohol beverages, Comparative Example 1 and Comparative Examples 2 to 2. A sensory test was conducted while comparing the tastes of the beer-flavored beverage to which 4 was added and the low-alcohol beverage.
表3及び表4に官能試験の対象とした評価試験区の処方の一覧を示す。なお、表3及び表4においては、ブランクとなるビール風味飲料、若しくは低アルコール飲料100重量部に対して、実施例1−1〜1−5、及び実施例2〜4に係る飲料用風味改善剤、並びに比較例1、及び比較例2〜4のいずれかを0.1重量部添加して調製した。 Tables 3 and 4 show a list of prescriptions for the evaluation test plots subject to the sensory test. In Tables 3 and 4, 100 parts by weight of the blank beer-flavored beverage or low-alcohol beverage is used to improve the flavor of beverages according to Examples 1-1 to 1-5 and Examples 2 to 4. It was prepared by adding 0.1 parts by weight of the agent and any of Comparative Examples 1 and 2 to 4.
各評価試験区を官能評価試験に供した。具体的には良く訓練され、日常飲料等の評価を行っているパネラー5人(n=5)が飲料を試飲し、ボディ感、苦味、味のキレ、味のバランス、総合評価について採点し、5人がつけた点数の平均値を評価として採用した。なお、評価点は、対象となるビール風味飲料、及び低アルコール飲料そのもの(ブランク)の各項目の評価点を一律に2.0とし、この2.0点を基準として各比較例及び実施例における各項目の呈味が良い評価であれば大きい点をつけることとして、「1、2、3、4、5」のいずれかの点数をつけることによって採点した。 Each evaluation test group was subjected to a sensory evaluation test. Specifically, five panelists (n = 5) who are well trained and evaluate daily beverages, etc. taste the beverage and score the body feeling, bitterness, sharpness of taste, balance of taste, and comprehensive evaluation. The average value of the scores given by the five people was adopted as the evaluation. As for the evaluation points, the evaluation points of each item of the target beer-flavored beverage and the low-alcohol beverage itself (blank) are uniformly set to 2.0, and the 2.0 points are used as a reference in each Comparative Example and Example. If the taste of each item is good, a large score is given, and a score of "1, 2, 3, 4, 5" is given.
本発明に記載しているボディ感とは、単一の香りや、単純なうま味やコク味による味覚のみで表現されるものでなく、さまざまな香り、風味の複雑さよりくる、質感について表す言葉である。飲料における「ボディ」とは、例えばワインの質感を表現する言葉としても使用されることがある。ワインにおいてはアルコール度数やタンニン、ワイン造りに使用するぶどう由来の香りに加え、保存に使用する樽の香りなどが合わさり、複雑な味や香りが寄与することが知られている。 The body feeling described in the present invention is not only expressed by a single scent or a taste by a simple umami or rich taste, but is a term that expresses a texture that comes from various scents and complexity of flavor. is there. The term "body" in a beverage may also be used, for example, to describe the texture of wine. In wine, it is known that the alcohol content, tannins, grape-derived aroma used for wine making, and the aroma of barrels used for preservation are combined to contribute to a complex taste and aroma.
以上の評価基準をもとに官能評価を行った各評価試験区の評価結果を表5〜表17に示す。 Tables 5 to 17 show the evaluation results of each evaluation test group for which sensory evaluation was performed based on the above evaluation criteria.
表5及び図1には、ビール風味飲料に係るブランクとしてノンアルコールビール(サントリーホールディングス株式会社製 オールフリー(登録商標))を使用したもの(以下、ブランク1という。)の前記評価項目を2.0とした場合の、ブランク1に実施例1−1〜1−4に係る乳酸菌発酵液を添加したものを表3の処方に従って作製して実施例5−1〜5−4としたもの、及び、ブランク1に実施例1−5及び比較例1に係る乳酸菌未発酵液を添加したものを表3の処方に従って作製して実施例5−5及び比較例5としたものの官能評価結果を示す。 Table 5 and FIG. 1 show the evaluation items of non-alcoholic beer (all-free (registered trademark) manufactured by Suntory Holdings Limited) as a blank for beer-flavored beverages (hereinafter referred to as blank 1). When it was set to 0, a blank 1 to which the lactic acid bacterium fermented solution according to Examples 1-1 to 1-4 was added was prepared according to the formulation in Table 3 and used as Examples 5-1 to 5-4. The sensory evaluation results of Examples 5-5 and Comparative Example 5 prepared by adding the unfermented lactic acid bacteria solution according to Example 1-5 and Comparative Example 1 to Blank 1 according to the formulation shown in Table 3 are shown.
表5の結果より、実施例5−1〜5−5は、いずれの評価項目においても評価基準としたブランク1の評価点2.0を上回り、かつ比較例5−1以上の結果を得た。ここで、比較例5と実施例5−5を比較すると、実施例5−5はいずれの評価項目においても比較例5を上回っており、D−アスパラギン酸、D−グルタミン酸、D−アロ−イソロイシンの添加により官能評価結果が向上することが示された。さらに、実施例5−5と実施例5−1を比較すると、実施例5−1はいずれの評価項目においても実施例5−5を上回る結果を得た。実施例5−5と実施例5−1はほぼ同量のD−アスパラギン酸、D−グルタミン酸、D−アロ−イソロイシンを含有しているため、D−アミノ酸以外の発酵生産物により、さらに評価結果が向上することが示された。 From the results in Table 5, Examples 5-1 to 5-5 exceeded the evaluation score 2.0 of Blank 1 as the evaluation standard in all the evaluation items, and obtained the results of Comparative Example 5-1 or higher. .. Here, when Comparative Example 5 and Example 5-5 are compared, Example 5-5 exceeds Comparative Example 5 in all the evaluation items, and D-aspartic acid, D-glutamic acid, and D-allo-isoleucine. It was shown that the addition of Glutamic acid improved the sensory evaluation results. Furthermore, when Example 5-5 and Example 5-1 were compared, the results of Example 5-1 were higher than those of Example 5-5 in all the evaluation items. Since Examples 5-5 and Example 5-1 contain approximately the same amount of D-aspartic acid, D-glutamic acid, and D-allo-isoleucine, further evaluation results are obtained using fermentation products other than D-amino acids. Was shown to improve.
表6及び図2には、前記ブランク1の前記評価項目を2.0とした場合の、ブランク1に実施例2に係る発酵米エキスを添加したものを表3の処方に従って作製して実施例6としたもの、及び、ブランク1に比較例2に係る未発酵米エキスを添加したものを表3の処方に従って作製して比較例6としたものの官能評価結果を示す。 In Table 6 and FIG. 2, when the evaluation item of the blank 1 is 2.0, a blank 1 to which the fermented rice extract according to Example 2 is added is prepared according to the formulation of Table 3 and is an example. The sensory evaluation results of the product No. 6 and the product prepared by adding the unfermented rice extract according to Comparative Example 2 to the blank 1 according to the formulation of Table 3 and used as Comparative Example 6 are shown.
表6の結果より、実施例6は、いずれの評価項目においても評価基準としたブランク1の評価点2.0を上回り、かつ比較例6以上の結果を得た。 From the results in Table 6, Example 6 exceeded the evaluation score 2.0 of Blank 1 as the evaluation standard in all the evaluation items, and obtained the results of Comparative Example 6 or higher.
表7及び図3には、前記ブランク1の前記評価項目を2.0とした場合の、ブランク1に実施例3に係る発酵モルトエキスを添加したものを表3の処方に従って作製して実施例7としたもの、及び、ブランク1に比較例3に係る未発酵モルトエキスを添加したものを表3の処方に従って作製して比較例7としたものの官能評価結果を示す。 In Table 7 and FIG. 3, when the evaluation item of the blank 1 is set to 2.0, a blank 1 to which the fermented malt extract according to Example 3 is added is prepared according to the formulation of Table 3 and is an example. The sensory evaluation results of the product of Comparative Example 7 and the product of blank 1 to which the unfermented malt extract according to Comparative Example 3 was added according to the formulation shown in Table 3 are shown.
表7の結果より、実施例7は、いずれの評価項目においても評価基準としたブランク1の評価点2.0を上回り、かつ比較例7以上の結果を得た。 From the results in Table 7, Example 7 exceeded the evaluation score 2.0 of Blank 1 as the evaluation standard in all the evaluation items, and obtained the results of Comparative Example 7 or higher.
表8及び図4には、前記ブランク1の前記評価項目を2.0とした場合の、ブランク1に実施例4に係る発酵白ブドウ果汁エキスを添加したものを表3の処方に従って作製して実施例8としたもの、及び、ブランク1に比較例4に係る未発酵白ブドウ果汁エキスを添加したものを表3の処方に従って作製して比較例8としたものの官能評価結果を示す。 In Table 8 and FIG. 4, when the evaluation item of the blank 1 was set to 2.0, a blank 1 to which the fermented white grape juice extract according to Example 4 was added was prepared according to the formulation of Table 3. The sensory evaluation results of the product of Example 8 and the product of blank 1 to which the unfermented white grape juice extract according to Comparative Example 4 was added according to the formulation shown in Table 3 and used as Comparative Example 8 are shown.
表8の結果より、実施例8は、いずれの評価項目においても評価基準としたブランク1の評価点2.0を上回り、かつ比較例8以上の結果を得た。 From the results in Table 8, in each of the evaluation items, the evaluation score 2.0 of the blank 1 as the evaluation standard was exceeded, and the results of Comparative Example 8 or more were obtained.
表9及び図5には、低アルコール飲料に係るブランクとして前記発泡酒(アサヒビール株式会社製 クリアアサヒ(登録商標))を使用したもの(以下、ブランク2という。)の前記評価項目を2.0とした場合の、ブランク2に実施例2に係る発酵米エキスを添加したものを表3の処方に従って作製して実施例9としたもの、及び、ブランク2に比較例2に係る未発酵米エキスを添加したものを表3の処方に従って作製して比較例9としたものの官能評価結果を示す。 In Table 9 and FIG. 5, the evaluation items of the one using the sparkling liquor (Clear Asahi (registered trademark) manufactured by Asahi Breweries, Ltd.) as the blank for the low-alcohol beverage (hereinafter referred to as blank 2) are shown in 2. When it was set to 0, the blank 2 to which the fermented rice extract according to Example 2 was added was prepared according to the formulation of Table 3 to be used as Example 9, and the blank 2 was prepared from the unfermented rice according to Comparative Example 2. The sensory evaluation results of the product to which the extract was added were prepared according to the formulation shown in Table 3 and used as Comparative Example 9 are shown.
表9の結果より、実施例9は、いずれの評価項目においても評価基準としたブランク2の評価点2.0を上回り、かつ比較例9以上の結果を得た。 From the results in Table 9, Example 9 exceeded the evaluation score 2.0 of Blank 2 as the evaluation standard in all the evaluation items, and obtained the results of Comparative Example 9 or higher.
表10及び図6には、前記ブランク2の前記評価項目を2.0とした場合の、ブランク2に実施例3に係る発酵モルトエキスを添加したものを表3の処方に従って作製して実施例10としたもの、及び、ブランク2に比較例3に係る未発酵モルトエキスを添加したものを表3の処方に従って作製して比較例10としたものの官能評価結果を示す。 In Table 10 and FIG. 6, when the evaluation item of the blank 2 is set to 2.0, a blank 2 to which the fermented malt extract according to Example 3 is added is prepared according to the formulation of Table 3 and is an example. The sensory evaluation results of the product set to 10 and the product prepared by adding the unfermented malt extract according to Comparative Example 3 to the blank 2 according to the formulation of Table 3 and set as Comparative Example 10 are shown.
表10の結果より、実施例10は、いずれの評価項目においても評価基準としたブランク2の評価点2.0を上回り、かつ比較例10以上の結果を得た。 From the results in Table 10, Example 10 exceeded the evaluation score 2.0 of Blank 2 as the evaluation standard in all the evaluation items, and obtained the results of Comparative Example 10 or more.
表11及び図7には、低アルコール飲料に係るブランクとして柑橘風味ノンアルコールチューハイ飲料(サントリーホールディングス株式会社 のんある気分(登録商標) 地中海レモン)(以下、ノンアルコールRTD(Ready to drink)という。)を使用したもの(以下、ブランク3という。)の前記評価項目を2.0とした場合の、ブランク3に実施例1−1〜1−4に係る乳酸菌発酵液を添加したものを表4の処方に従って作製して実施例11−1〜11−4としたもの、及び、ブランク3に実施例1−5及び比較例1に係る乳酸菌未発酵液を添加したものを表4の処方に従って作製して実施例11−5及び比較例11としたものの官能評価結果を示す。 In Table 11 and FIG. 7, citrus-flavored non-alcoholic chu-hi beverage (Suntory Holdings Limited, Non-alcoholic mood (registered trademark) Mediterranean lemon) (hereinafter referred to as non-alcoholic RTD (Ready to drink)) is referred to as a blank for low-alcoholic beverages. ) (Hereinafter referred to as blank 3), when the evaluation item is 2.0, the blank 3 to which the lactic acid bacterium fermented solution according to Examples 1-1 to 1-4 is added is shown in Table 4. 11-1 to 11-4, and blank 3 to which the lactic acid bacteria unfermented liquids according to Examples 1-5 and Comparative Example 1 were added were prepared according to the formulation shown in Table 4. The sensory evaluation results of Examples 11-5 and Comparative Example 11 are shown below.
表11の結果より、実施例11−1〜11−5は、いずれの評価項目においても評価基準としたブランク3の評価点2.0を上回り、かつ比較例11以上の結果を得た。ここで、比較例11と実施例11−5を比較すると、実施例11−5はいずれの評価項目においても比較例11を上回っており、D−アスパラギン酸、D−グルタミン酸、D−アロ−イソロイシンの添加により官能評価結果が向上することが示された。さらに、実施例11−5と実施例11−1を比較すると、実施例11−1はいずれの評価項目においても実施例11−5を上回る結果を得た。実施例11−5と実施例11−1はほぼ同量のD−アスパラギン酸、D−グルタミン酸、D−アロ−イソロイシンを含有しているため、D−アミノ酸以外の発酵生産物により、さらに評価結果が向上することが示された。 From the results in Table 11, Examples 11-1 to 11-5 exceeded the evaluation score 2.0 of Blank 3 as the evaluation standard in all the evaluation items, and obtained the results of Comparative Example 11 or higher. Here, when Comparative Example 11 and Example 11-5 are compared, Example 11-5 exceeds Comparative Example 11 in all the evaluation items, and D-aspartic acid, D-glutamic acid, and D-allo-isoleucine. It was shown that the addition of Glutamic acid improved the sensory evaluation results. Furthermore, when Example 11-5 and Example 11-1 were compared, the results of Example 11-1 were higher than those of Example 11-5 in all the evaluation items. Since Examples 11-5 and Example 11-1 contain approximately the same amount of D-aspartic acid, D-glutamic acid, and D-allo-isoleucine, further evaluation results are obtained using fermentation products other than D-amino acids. Was shown to improve.
表12及び図8には、前記ブランク3の前記評価項目を2.0とした場合の、ブランク3に実施例2に係る発酵米エキスを添加したものを表4の処方に従って作製して実施例12としたもの、及び、ブランク3に比較例2に係る未発酵米エキスを添加したものを表4の処方に従って作製して比較例12としたものの官能評価結果を示す。 In Table 12 and FIG. 8, when the evaluation item of the blank 3 is 2.0, a blank 3 to which the fermented rice extract according to Example 2 is added is prepared according to the formulation of Table 4 and is an example. The sensory evaluation results of the product No. 12 and the product prepared by adding the unfermented rice extract according to Comparative Example 2 to the blank 3 according to the formulation of Table 4 and used as Comparative Example 12 are shown.
表12の結果より、実施例12は、いずれの評価項目においても評価基準としたブランク3の評価点2.0を上回り、かつ比較例12以上の結果を得た。 From the results in Table 12, Example 12 exceeded the evaluation score 2.0 of Blank 3 as the evaluation standard in all the evaluation items, and obtained the results of Comparative Example 12 or higher.
表13及び図9には、前記ブランク3の前記評価項目を2.0とした場合の、ブランク3に実施例3に係る発酵モルトエキスを添加したものを表4の処方に従って作製して実施例13としたもの、及び、ブランク3に比較例3に係る未発酵モルトエキスを添加したものを表4の処方に従って作製して比較例13としたものの官能評価結果を示す。 In Tables 13 and 9, when the evaluation item of the blank 3 is set to 2.0, a blank 3 to which the fermented malt extract according to Example 3 is added is prepared according to the formulation of Table 4 and is an example. The sensory evaluation results of the product No. 13 and the product prepared by adding the unfermented malt extract according to Comparative Example 3 to the blank 3 according to the formulation of Table 4 and used as Comparative Example 13 are shown.
表13の結果より、実施例13は、いずれの評価項目においても評価基準としたブランク3の評価点2.0を上回り、かつ比較例13以上の結果を得た。 From the results in Table 13, in each of the evaluation items, the evaluation score 2.0 of the blank 3 used as the evaluation standard was exceeded, and the results of Comparative Example 13 or more were obtained.
表14及び図10には、前記ブランク3の前記評価項目を2.0とした場合の、ブランク3に実施例4に係る発酵白ブドウエキスを添加したものを表4の処方に従って作製して実施例14としたもの、及び、ブランク3に比較例4に係る未発酵白ブドウエキスを添加したものを表4の処方に従って作製して比較例14としたものの官能評価結果を示す。 In Table 14 and FIG. 10, when the evaluation item of the blank 3 was set to 2.0, a blank 3 to which the fermented white grape extract according to Example 4 was added was prepared according to the formulation of Table 4 and carried out. The sensory evaluation results of Example 14 and Blank 3 to which the unfermented white grape extract according to Comparative Example 4 was added were prepared according to the formulation shown in Table 4 and used as Comparative Example 14.
表14の結果より、実施例14は、いずれの評価項目においても評価基準としたブランク3の評価点2.0を上回り、かつ比較例14以上の結果を得た。 From the results in Table 14, Example 14 exceeded the evaluation score 2.0 of Blank 3 as the evaluation standard in all the evaluation items, and obtained the results of Comparative Example 14 or higher.
表15及び図11には、低アルコール飲料に係るブランクとして柑橘風味チューハイ飲料(キリンビール株式会社製 氷結(登録商標) グレープフルーツ)(以下、低アルコールRTDという。)を使用したもの(以下、ブランク4という。)の前記評価項目を2.0とした場合の、ブランク4に実施例2に係る発酵米エキスを添加したものを表4の処方に従って作製して実施例15としたもの、及び、ブランク4に比較例2に係る未発酵米エキスを添加したものを表4の処方に従って作製して比較例15としたものの官能評価結果を示す。 In Table 15 and FIG. 11, a citrus-flavored chu-hi beverage (freezing (registered trademark) grapefruit manufactured by Kirin Brewery Co., Ltd.) (hereinafter referred to as low-alcohol RTD) was used as a blank for the low-alcohol beverage (hereinafter, blank 4). When the evaluation item of () is 2.0, a blank 4 to which the fermented rice extract according to Example 2 is added is prepared according to the formulation of Table 4 and used as Example 15, and a blank. The sensory evaluation results of Comparative Example 15 prepared by adding the unfermented rice extract according to Comparative Example 2 to 4 according to the formulation shown in Table 4 are shown.
表15の結果より、実施例15は、いずれの評価項目においても評価基準としたブランク4の評価点2.0を上回り、かつ比較例15以上の結果を得た。 From the results in Table 15, the results of Example 15 exceeded the evaluation score 2.0 of Blank 4 as the evaluation standard in all the evaluation items, and the results of Comparative Example 15 or higher were obtained.
表16及び図12には、前記ブランク4の前記評価項目を2.0とした場合の、ブランク4に実施例3に係る発酵モルトエキスを添加したものを表4の処方に従って作製して実施例16としたもの、及び、ブランク4に比較例3に係る未発酵モルトエキスを添加したものを表4の処方に従って作製して比較例16としたものの官能評価結果を示す。 In Table 16 and FIG. 12, when the evaluation item of the blank 4 is set to 2.0, a blank 4 to which the fermented malt extract according to Example 3 is added is prepared according to the formulation of Table 4 and is an example. The sensory evaluation results of the product set to 16 and the blank 4 to which the unfermented malt extract according to Comparative Example 3 was added were prepared according to the formulation shown in Table 4 and used as Comparative Example 16.
表16の結果より、実施例16は、いずれの評価項目においても評価基準としたブランク4の評価点2.0を上回り、かつ比較例16以上の結果を得た。 From the results in Table 16, Example 16 exceeded the evaluation score 2.0 of Blank 4 as the evaluation standard in all the evaluation items, and obtained the results of Comparative Example 16 or higher.
表17及び図13には、前記ブランク4の前記評価項目を2.0とした場合の、ブランク4に実施例4に係る発酵白ブドウエキスを添加したものを表4の処方に従って作製して実施例17としたもの、及び、ブランク4に比較例4に係る未発酵白ブドウエキスを添加したものを表4の処方に従って作製して比較例17としたものの官能評価結果を示す。 In Tables 17 and 13, when the evaluation item of the blank 4 was set to 2.0, a blank 4 to which the fermented white grape extract according to Example 4 was added was prepared according to the formulation of Table 4 and carried out. The sensory evaluation results of the example 17 and the blank 4 to which the unfermented white grape extract according to the comparative example 4 was added were prepared according to the formulation shown in Table 4 and used as the comparative example 17.
表17の結果より、実施例17は、いずれの評価項目においても評価基準としたブランク4の評価点2.0を上回り、かつ比較例17以上の結果を得た。 From the results in Table 17, the results of Example 17 exceeded the evaluation score 2.0 of Blank 4 as the evaluation standard in all the evaluation items, and the results of Comparative Example 17 or higher were obtained.
以上の評価結果は、実施例5−1〜実施例17の全てにおいて、いずれの項目においても評価点2.5を上回っており、ブランクに対して明確な味の向上が得られたことを示すものである。ブランク1〜4の飲料(評価点2.0)に対して本発明に係る飲料用風味改善剤を添加して実施例5−1〜実施例17を調製すると、その全てにおいてボディ感が向上し、また、味のキレが向上し、さらにまた、ボディ感と苦味とが向上して味のバランスも向上した。本発明に係る飲料用風味改善剤によれば、実施例に係るいずれの飲料にも十分な飲みごたえと苦味を付与しつつ、かつ自然な風味バランスを維持する効果を発揮できることが明らかとなった。 The above evaluation results exceeded the evaluation score of 2.5 in all of the items in Examples 5-1 to 17, indicating that a clear improvement in taste was obtained with respect to the blank. It is a thing. When Examples 5-1 to Example 17 are prepared by adding the beverage flavor improving agent according to the present invention to the beverages (evaluation points 2.0) of blanks 1 to 4, the body feeling is improved in all of them. In addition, the sharpness of the taste was improved, and the body feeling and bitterness were also improved, and the balance of taste was also improved. According to the beverage flavor improving agent according to the present invention, it has been clarified that any of the beverages according to the examples can exert an effect of maintaining a natural flavor balance while imparting a sufficient drinkability and bitterness. ..
一方、比較例5〜比較例17の全てにおいて、いずれの項目においても評価点2.5を上回るものはなかった。特に、ボディ感と苦味、味のバランスにおいて評価点2.5を上回るものは見られなかった。これより、これらの項目の評価点が3.0を上回った実施例5−1〜5−4、実施例6〜10、実施例11−1〜11−4、実施例12〜17との顕著な差異が明らかとなった。 On the other hand, in all of Comparative Examples 5 to 17, none of the items exceeded the evaluation score of 2.5. In particular, none of them exceeded the evaluation score of 2.5 in terms of body feeling, bitterness, and taste balance. From this, it is remarkable that the evaluation points of these items exceeded 3.0 in Examples 5-1 to 5-4, Examples 6 to 10, Examples 11 to 11-4, and Examples 12 to 17. Differences became clear.
また、実施例5−5、実施例11−5においては、いずれの項目においても評価点2.5を上回っており、D−アスパラギン酸、D−グルタミン酸、D−アロ−イソロイシンを添加することで、ブランクに対してボディ感が向上し、また、味のキレが向上し、さらにまた、ボディ感と苦味とが向上して味のバランスも向上することが明確に示された。さらに、実施例5−5と実施例5−1、実施例11−5と実施例11−1を比較すると、それぞれほぼ同量のD−アスパラギン酸、D−グルタミン酸、D−アロ−イソロイシンを含有しているにも関わらず、いずれの項目においても実施例5−1および実施例11−1のほうが高い評価点を示した。すなわち、D−アスパラギン酸、D−グルタミン酸、D−アロ−イソロイシンに加えてD−アミノ酸以外の発酵生産物も添加することにより、ボディ感が向上し、また、味のキレが向上し、さらにまた、ボディ感と苦味とが向上して味のバランスも向上することが示された。 Further, in Examples 5-5 and 11-5, the evaluation points were higher than 2.5 in all the items, and by adding D-aspartic acid, D-glutamic acid, and D-allo-isoleucine, It was clearly shown that the body feeling was improved with respect to the blank, the sharpness of the taste was improved, the body feeling and the bitterness were improved, and the taste balance was also improved. Furthermore, when Example 5-5 and Example 5-1 and Examples 11-5 and 11-1 are compared, they contain substantially the same amounts of D-aspartic acid, D-glutamic acid, and D-allo-isoleucine, respectively. In spite of this, Examples 5-1 and Example 11-1 showed higher evaluation points in all items. That is, by adding a fermented product other than D-amino acid in addition to D-aspartic acid, D-glutamic acid, and D-allo-isoleucine, the body feeling is improved, the taste sharpness is improved, and further. It was shown that the body feeling and bitterness were improved and the balance of taste was also improved.
表2を見ると、実施例1〜実施例4のうち、実施例2にてD−アスパラギン酸濃度及びD−アロ―イソロイシン濃度が最も低く、それぞれ9ppm、4ppmであった。なお、実施例2におけるD−グルタミン酸濃度は38ppmであった。また、D−グルタミン酸濃度は実施例3で最も低く、29ppmであった。これらを0.1%添加した飲料である実施例6、実施例7、実施例9、実施例10、実施例12、実施例13、実施例15、実施例16の全てにおいて、高い評価点が示されている。これらの実施例に基づくと、飲料中にD−アスパラギン酸濃度が0.009ppm、D−グルタミン酸濃度が0.029ppm、及びD−アローイソロイシン濃度が0.004ppmという、非常に低濃度の含有量から、十分な風味改善効果を得られると思われる。 Looking at Table 2, among Examples 1 to 4, the D-aspartic acid concentration and the D-aro-isoleucine concentration were the lowest in Example 2, which were 9 ppm and 4 ppm, respectively. The concentration of D-glutamic acid in Example 2 was 38 ppm. The concentration of D-glutamic acid was the lowest in Example 3 and was 29 ppm. High evaluation points were given in all of Example 6, Example 7, Example 9, Example 10, Example 12, Example 13, Example 15, and Example 16 which are beverages to which 0.1% of these are added. It is shown. Based on these examples, from very low concentrations of D-aspartic acid concentration of 0.009 ppm, D-glutamic acid concentration of 0.029 ppm, and D-arrow isoleucine concentration of 0.004 ppm in the beverage. , It seems that a sufficient flavor improvement effect can be obtained.
本発明に係るD−アスパラギン酸、D−グルタミン酸、D−アロ−イソロイシンを含有する飲料用風味改善剤を添加することによって、または乳酸菌による発酵処理によって生成された発酵処理物としてD−アスパラギン酸、D−グルタミン酸、D−アロ−イソロイシンを含有する飲料用風味改善剤を添加することによって、ビール風味飲料、及び低アルコール飲料に対して、ボディ感と苦味を向上させ、かつ自然な風味バランスを維持した飲料とすることができる。
D-aspartic acid, as a fermented product produced by the addition of a beverage flavor improver containing D-aspartic acid, D-glutamic acid, D-allo-isoleucine according to the present invention, or by fermentation treatment with lactic acid bacteria. By adding a beverage flavor improver containing D-glutamic acid and D-allo-aspartic acid, the body feeling and bitterness are improved and the natural flavor balance is maintained for beer-flavored beverages and low-alcohol beverages. Can be a low-alcohol beverage.
Claims (12)
A method for improving the flavor of a beverage, which comprises containing 0.009 ppm or more of D-aspartic acid, 0.029 ppm or more of D-glutamic acid, and 0.004 ppm or more of D-aro-isoleucine in the beverage.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2019091200 | 2019-05-14 | ||
JP2019091200 | 2019-05-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2020188753A true JP2020188753A (en) | 2020-11-26 |
Family
ID=73453509
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2020051468A Pending JP2020188753A (en) | 2019-05-14 | 2020-03-23 | Beverage flavor-improver |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2020188753A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2022086854A (en) * | 2020-11-30 | 2022-06-09 | 中野Bc株式会社 | Foam stabilizer or foam promoter |
WO2022168691A1 (en) * | 2021-02-03 | 2022-08-11 | サントリーホールディングス株式会社 | Non-alcoholic-beer-taste beverage |
JP7449250B2 (en) | 2021-02-03 | 2024-03-13 | サントリーホールディングス株式会社 | beer taste alcoholic beverage |
-
2020
- 2020-03-23 JP JP2020051468A patent/JP2020188753A/en active Pending
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2022086854A (en) * | 2020-11-30 | 2022-06-09 | 中野Bc株式会社 | Foam stabilizer or foam promoter |
WO2022168691A1 (en) * | 2021-02-03 | 2022-08-11 | サントリーホールディングス株式会社 | Non-alcoholic-beer-taste beverage |
JP7449250B2 (en) | 2021-02-03 | 2024-03-13 | サントリーホールディングス株式会社 | beer taste alcoholic beverage |
JP7487352B2 (en) | 2021-02-03 | 2024-05-20 | サントリーホールディングス株式会社 | Non-alcoholic beer-flavored beverage |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6669708B2 (en) | Beverage flavor improver | |
JP2020188753A (en) | Beverage flavor-improver | |
JP2021036907A (en) | Non-sweet beverage | |
JP2011036129A (en) | Beer-taste fermented beverage with high alcohol content | |
JP7312432B2 (en) | Beverage flavor and food flavor | |
WO2018074014A1 (en) | Beer-tasting beverage | |
JP2010227055A (en) | Method for producing vinegar having excellent flavor, vinegar produced by the same and vinegar-containing food and drink | |
JP5119352B2 (en) | Method for producing high-gap content Happoshu | |
JP2020127399A (en) | Production method of flavor improver | |
JP2012147775A (en) | Tea-based alcoholic beverage | |
JP2020025506A (en) | Novel lactic acid bacterium and method for producing soy sauce using the same | |
JP2011000050A (en) | Sparkling liquor and method for producing the same | |
JP2022021205A (en) | Milk flavor improver and method for improving milk flavor of food and drink | |
JP2015130845A (en) | Beer-taste beverage packed in container, and manufacturing method therefor | |
JP3587804B2 (en) | Vinegar, production method thereof, and food and beverage containing the vinegar | |
TWI747409B (en) | Composition for food and drink and its manufacturing method | |
JP7428715B2 (en) | Composition for food and drink | |
JP7344562B2 (en) | flavor improver | |
JP2020103222A (en) | Production method of liquor using indole production yeast, indole high production yeast and breeding method thereof | |
JP5767385B1 (en) | Method for producing fermented beverage | |
JP2015033340A (en) | Spirit-containing seasoning and production method thereof | |
JP7138354B2 (en) | Salt-tolerant yeast and fermented product using the same | |
JP7018305B2 (en) | High alcohol concentration beer taste alcoholic beverages and their manufacturing methods | |
JPH11318427A (en) | Liquors having free radical-eliminating ability and its production | |
JP2022020997A (en) | Saltiness enhancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20200324 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20221220 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20231108 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20231114 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20240115 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240207 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20240507 |